4th Quarter - Report

AMERICAN CLINICAL LABORATORY ASSN for AMERICAN CLINICAL LABORATORY ASSN

Firm
Client
Income
—
Expenses
$510,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, test coding and pricing, coverage, and payment, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); FDA and CMS policies related to diagnostics and laboratory regulation; public-private sector testing response in general and specific to Influenza A (H5) avian flu, monkeypox and oropouche; H.R. 2377/S. 1000, Saving Access to Laboratory Services Act; H.R. 8702/S. 4532, Improving Seniors Timely Access to Care Act; and H.R. 2369, the Verifying Accurate Leading-edge IVCT Development Act (VALID Act) of 2023.

LobbyistCovered position, as disclosed
HOLLY GROSHOLZ —
SUSAN VAN METER —
MARY LEE WATTS —

Contacted: Natl Security Council (NSC); White House Office; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Bills named: H.R. 8702 (118th), S. 1000 (118th), H.R. 2377 (118th), S. 4532 (118th), H.R. 2369 (118th)

Medicare/Medicaid MMM

Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, test coding and pricing, coverage, and payment, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); H.R. 2377/S. 1000, Saving Access to Laboratory Services Act; H.R. 8702/S. 4532, Improving Seniors Timely Access to Care Act.

LobbyistCovered position, as disclosed
HOLLY GROSHOLZ —
SUSAN VAN METER —
MARY LEE WATTS —

Contacted: White House Office; SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 4532 (118th), S. 1000 (118th), H.R. 8702 (118th), H.R. 2377 (118th)

Health Issues HCR

Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, test coding and pricing, coverage, and payment, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); FDA and CMS policies related to diagnostics and laboratory regulation; price transparency for clinical laboratory services; H.R. 2377/S. 1000, Saving Access to Laboratory Services Act; H.R. 8818, Improving Seniors Timely Access to Care Act; H.R. 2369, the Verifying Accurate Leading-edge IVCT Development Act (VALID Act) of 2023; S. 3548.

LobbyistCovered position, as disclosed
HOLLY GROSHOLZ —
SUSAN VAN METER —
MARY LEE WATTS —

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Bills named: S. 3548 (118th), H.R. 2377 (118th), S. 1000 (118th), H.R. 8818 (118th), H.R. 2369 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.